SF3B1 mutations in myelodysplastic syndromes: A potential therapeutic target for modulating the entire disease process

Myelodysplastic syndromes (MDS) are clonal hematologic malignancies characterized by ineffective hematopoiesis and dysplasia of the myeloid cell lineage and are characterized by peripheral blood cytopenia and an increased risk of transformation to acute myeloid leukemia (AML). Approximately half of...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Moqin, Chen, Meng, Liu, Qian, Jin, Zhiling, Yang, Xiangdong, Zhang, Weifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063959/
https://www.ncbi.nlm.nih.gov/pubmed/37007111
http://dx.doi.org/10.3389/fonc.2023.1116438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063959/
https://www.ncbi.nlm.nih.gov/pubmed/37007111
http://dx.doi.org/10.3389/fonc.2023.1116438

Ejemplares similares